| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |